The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: SmithKline Beecham
Approval Status: Approved January 1999
Treatment for: Infectious Diseases
General Information
For the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients.